“…Our results showed disturbances of these transports accord ing to clinical subgroups of patients, (DSM III classifica tion), as compared with controls. The aim of our general study is to facilitate the drug therapy, with maximum benefit to the patients [Bovier et al, 1988a[Bovier et al, , 1988b; Azorin et al, 1990], In parallel with clinical applications, we attempted to characterize better these peripheral trans port mechanisms by using inhibitors of electrolyte move ments, such as phloretin, furosemide, ouabain, nonactin, A 23387 and others, and by studying the involvement of the membrane fluidity [Widmer et al, 1986[Widmer et al, . 1987, Recently, we found that sulfhydric reagents such as parachloromercuribenzenesulfonate, a nonmembranepenetrating agent, or N-ethylmaieimide, inhibited the transport of both amino acids.…”